CNTB
Connect Biopharma Holdings Limited · Healthcare
Insiders bought $4.4M of Connect Biopharma Holdings Limited in the last 12 months
1 insider bought on 2 days.
$4.4MBought, 12 mo
$0Sold, 12 mo
$57.9MMarket cap
CNTB over the last year
Largest buyers, last 12 months
CNTB after insider buys
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Every filing
2 insider filings since 2026, newest first
About Connect Biopharma Holdings Limited
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.